Status | Study |
Recruiting |
Study Name: A Study of Andrographolide Sulfonate in Patients With Acute Exacerbation of Chronic Bronchitis Condition: Acute Exacerbation of Chronic Bronchitis Date: 2017-04-13 Interventions: Drug: andrographolide sulfonate |
Recruiting |
Study Name: Gala FIH Feasibility Study for the Treatment of Chronic Bronchitis Condition: Chronic Bronchitis Date: 2017-03-30 Interventions: Device: Gala Airway Treatment System The Gala Airway Treatment system is a device-based, energy delivery |
Completed |
Study Name: Mucolytic Effectiveness of Tacholiquine ® in Chronic Bronchitis Condition: Bronchitis, Chronic Pulmonary Disease, Chronic Obstructive Date: 2015-07-24 Interventions: Drug: Tacholiquine Inhaled Tac |
Recruiting |
Study Name: Safety and Feasibility Study of Rejuvenair™ for Treating Chronic Bronchitis Patients Condition: Bronchitis, Chronic Cryotherapy Effect Date: 2015-06-25 Interventions: Device: RejuvenAir Device: RejuvenAir |
Recruiting |
Study Name: Effect of Losartan on Airway Mucociliary Dysfunction in Patients With COPD and Chronic Bronchitis Condition: COPD Chronic Bronchitis Date: 2015-01-16 Interventions: Drug: Losartan 50 mg COPD and |
Completed |
Study Name: Comparative Evaluate the Efficacy to Acute and Chronic Bronchitis Condition: Acute Exacerbation of Chronic Bronchitis Date: 2013-10-31 Interventions: Drug: Combination of Broussonetia spp and Lonicera spp 600 mg/ day or 1200 mg/ day for 7 days |
Terminated |
Study Name: N-Acetylcysteine for Patients With COPD and Chronic Bronchitis Condition: COPD Chronic Bronchitis Date: 2012-11-29 Interventions: Drug: N-Acetylcysteine 1800 mg |
Completed |
Study Name: Safety/Tolerability and Efficacy of YHD001 in Patients With Acute and Chronic Bronchitis Condition: Acute Bronchitis Chronic Bronchitis Date: 2011-07-20 Interventions: Drug: YHD001 dose level 1 thre |
Completed |
Study Name: VICTOR - Avelox® Intravenous (i.v.) in Acute Exacerbations of Chronic Bronchitis Condition: Chronic Bronchitis Disease Exacerbation Date: 2009-04-03 Interventions: Drug: Moxifloxacin (Avelox, BAY12-8039) Patients from the normal praxis routine, treated with Moxifloxac |
Completed |
Study Name: AVANTI - Avelox® in Acute Exacerbations of chroNic bronchiTIs Condition: Bronchitis, Chronic Date: 2009-02-18 Interventions: Drug: Moxifloxacin (Avelox, BAY12-8039) Patients with acute exacerbation of chronic bronchitis for whom |